Merck announces presentation of interim data from study evaluating Lambrolizumab
Merck expands Lambrolizumab clinical development program...
2 June 2013 | By Merck
Merck expands Lambrolizumab clinical development program...
List view / Grid view
Merck expands Lambrolizumab clinical development program...
2 June 2013 | By Merck
Merck expands Lambrolizumab clinical development program...
Novel personalized treatment approach targets folate receptors on cancer cells...
27 November 2012 | By Merck
Novel personalized treatment approach targets folate receptors on cancer cells...
Merck announced the presentation of early interim results...
11 November 2012 | By Merck
Merck announced the presentation of early interim results...